Has Covid-19 impacted access to Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 17 September 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

New research has found that the coronavirus pandemic has affected access to medication for people living with Parkinson’s disease.

The sub-study used information from a survey conducted by the International Parkinson and Movement Disorder Society. The results from 346 participants showed that 22.8% of high-income and 88.9% of low-income countries’ respondents agreed that the coronavirus crisis had impacted people’s access to Parkinson’s medication. Some respondents reported increased disability, increased hospitalisation and increased mortality as factors. The majority of those who completed the survey were doctors.

The researchers concluded: “Our results offer preliminary data that the Covid-19 pandemic has affected Parkinson’s disease patients’ access to regular medication.

“Covid-19 has diverted resources away from chronic conditions towards the fight against Covid-19 in many countries. Resource-poor countries seem to be disproportionately affected compared to their affluent counterparts.”


Read more:

Brazilian dance could improve mobility in people with Parkinson’s, study finds

#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’

Go Back

Share this story

Comments


Related articles


Cure Parkinson's Trust cyclists outdoors

Global update

Parkinson’s in the news: June

We round up the top Parkinson’s news stories from around the globe

READ MORE

Resources & Tools

Brush up on your Parkinson’s terminology with this free glossary

Free downloadable and printable A-Z of Parkinson’s disease

READ MORE
Parkinsoniada

Health & Fitness

The 8th Parkinson’s ‘Olympics’ targets key exercise habits

It’s the exercise that counts at the Parkinsoniada games

READ MORE